Effect and cost of subcutaneous recombinant human erythropoietin in preoperative patients.
Jafari-Fesharaki
M
M
Department of Clinical Pharmacy, University of California, San Francisco, USA.
Toy
P
P
D000279:Administration, Cutaneous; D003362:Cost-Benefit Analysis; D004921:Erythropoietin / Q000191:economics* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009985:Orthopedics; D011300:Preoperative Care; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin